The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients - Riddle, M C; Rosenstock, J; Gerich, J; Insulin Glargine 4002 Study Investigators (Diabetes Care, 2003)